Feb 15 2010
International Merchant Advisors, Inc. (Pink Sheets: IMAI) announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector. The pharmaceutical company has gross revenues in eight figures, but will not be identified until IMAI has a signed letter of intent from the company for the proposed investment transaction.
Mel Roseman, CEO commented, "We recently announced our intention to enter the healthcare services sector, with a particular interest in chronic pain management and wellness centers. With the advent of healthcare reform and continuing pressure on reimbursements from Medicare, Medicaid, and insurance companies, we believe alternative, lower cost wellness centers have great promise. Just today, the Obama Administration Health and Human Services Secretary Kathleen Sebelius criticized Wellpoint, Inc. for its proposed 38% increase in premiums for Californians even though Wellpoint just released earnings in excess of $2 billion. The market is looking for more efficient and less expensive healthcare solutions, and we believe this is a part of that solution demanded by the market.
Source:
International Merchant Advisors, Inc.